Yuko Nagaoki

1.9k total citations
46 papers, 745 citations indexed

About

Yuko Nagaoki is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Yuko Nagaoki has authored 46 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 23 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Yuko Nagaoki's work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (17 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Yuko Nagaoki is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (17 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Yuko Nagaoki collaborates with scholars based in Japan, Cambodia and Burkina Faso. Yuko Nagaoki's co-authors include Kazuaki Chayama, Hiroshi Aikata, Akira Hiramatsu, Tomokazu Kawaoka, Michio Imamura, Takashi Nakahara, Yoshiiku Kawakami, Masataka Tsuge, Shintaro Takaki and Shoichi Takahashi and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Medical Virology.

In The Last Decade

Yuko Nagaoki

42 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Nagaoki Japan 15 517 374 164 85 84 46 745
Manuel de Juan Spain 14 728 1.4× 554 1.5× 380 2.3× 63 0.7× 105 1.3× 32 1.0k
Nathan Rubin United States 14 59 0.1× 175 0.5× 91 0.6× 92 1.1× 66 0.8× 60 583
Sandeep Dhaliwal Canada 12 226 0.4× 205 0.5× 163 1.0× 125 1.5× 101 1.2× 25 620
Christine Caron France 16 266 0.5× 337 0.9× 238 1.5× 160 1.9× 166 2.0× 39 918
Sudhamshi Toom United States 5 56 0.1× 81 0.2× 49 0.3× 150 1.8× 85 1.0× 12 626
Manoj K. Singh India 13 158 0.3× 64 0.2× 255 1.6× 68 0.8× 119 1.4× 33 438
Joshua H. Wolf United States 13 120 0.2× 79 0.2× 280 1.7× 151 1.8× 70 0.8× 44 771
Jason J. Schwartz United States 14 213 0.4× 182 0.5× 500 3.0× 195 2.3× 239 2.8× 35 855
Edmund Sabo Israel 9 123 0.2× 78 0.2× 126 0.8× 30 0.4× 45 0.5× 15 517
Olga Ciccarelli Belgium 19 637 1.2× 297 0.8× 688 4.2× 131 1.5× 73 0.9× 80 1.2k

Countries citing papers authored by Yuko Nagaoki

Since Specialization
Citations

This map shows the geographic impact of Yuko Nagaoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Nagaoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Nagaoki more than expected).

Fields of papers citing papers by Yuko Nagaoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Nagaoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Nagaoki. The network helps show where Yuko Nagaoki may publish in the future.

Co-authorship network of co-authors of Yuko Nagaoki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Nagaoki. A scholar is included among the top collaborators of Yuko Nagaoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Nagaoki. Yuko Nagaoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagaoki, Yuko, et al.. (2023). Impact of labor analgesia on mode of delivery and neonatal outcomes in Japan: A retrospective cohort study. PLoS ONE. 18(4). e0284368–e0284368. 3 indexed citations
3.
Nagaoki, Yuko, Aya Sugiyama, Serge Ouoba, et al.. (2022). Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample. Hepatology Research. 52(11). 908–918. 7 indexed citations
4.
Ito, Masanori, Aya Sugiyama, Yuko Nagaoki, et al.. (2022). Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study. Journal of Gastroenterology. 57(8). 540–546. 5 indexed citations
5.
Oka, Shiro, Hiroshi Aikata, Akiyoshi Tsuboi, et al.. (2019). Exacerbation of Portal Hypertensive Enteropathy after Endoscopic Injection Sclerotherapy for Esophageal Varices. Digestion. 102(2). 188–196. 4 indexed citations
8.
Kawaoka, Tomokazu, Hiroshi Aikata, Yuji Teraoka, et al.. (2017). Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib. Oncology. 92(6). 335–346. 11 indexed citations
9.
Kawaoka, Tomokazu, Takashi Nakahara, Yuko Nagaoki, et al.. (2017). Late-onset ornithine transcarbamylase deficiency associated with hyperammonemia. Clinical Journal of Gastroenterology. 10(4). 383–387. 14 indexed citations
10.
Kobayashi, Tomoki, Hiroshi Aikata, Fumi Honda, et al.. (2016). Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma. Journal of Computer Assisted Tomography. 40(4). 524–530. 39 indexed citations
11.
Nakagawa, Machiko, Hidenobu Ohta, Yuko Nagaoki, et al.. (2016). Daytime nap controls toddlers’ nighttime sleep. Scientific Reports. 6(1). 27246–27246. 27 indexed citations
12.
Kobayashi, Tomoki, Yoshiiku Kawakami, Akira Hiramatsu, et al.. (2013). A case of acute hepatitis C with hepatitis C virus (HCV) genotype 3a -discussion of IL28-B-. Kanzo. 54(2). 120–127.
13.
Kawaoka, Tomokazu, Hiroshi Aikata, Eisuke Murakami, et al.. (2012). Evaluation of the mRECIST and α-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib. Oncology. 83(4). 192–200. 55 indexed citations
14.
Nagaoki, Yuko, Hiroshi Aikata, Tomoki Kobayashi, et al.. (2012). Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis. Journal of Gastroenterology. 48(7). 847–855. 14 indexed citations
15.
Aikata, Hiroshi, Tomokazu Kawaoka, Eisuke Murakami, et al.. (2011). A case report of perforation of the colon during the sorafenib therapy for hepatocellular carcinoma. Kanzo. 52(12). 777–783.
16.
Murakami, Eisuke, Hiroshi Aikata, Daisuke Miyaki, et al.. (2011). Comparison of Sorafenib response evaluation with RECIST, mRECIST and RECICL for hepatocellular carcinoma. Kanzo. 52(5). 322–324. 4 indexed citations
18.
Nagaoki, Yuko, Hideyuki Hyogo, Hiroshi Aikata, et al.. (2011). Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatology Research. 42(4). 368–375. 78 indexed citations
20.
Okajima, Hideaki, Yuki Ohya, Hidekazu Yamamoto, et al.. (2009). Management of undifferentiated sarcoma of the liver including living donor liver transplantation as a backup procedure. Journal of Pediatric Surgery. 44(2). e33–e38. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026